Chandigarh [India], February 28: SeraSeal™, the world's first and only primary hemostatic agent, has been approved for use in trauma and emergency bleed management under the Nammai Kaakkum 48 (NK-48) scheme of the Chief Minister's Comprehensive Health Insurance Scheme (CMCHiS) in Tamil Nadu. This milestone approval will strengthen emergency care across 702 empanelled state hospitals, covering a wide range of specialties including neuro, ENT, spine, cardiac, vascular, liver, kidney transplant, and orthopedic surgeries.